Provided by Tiger Fintech (Singapore) Pte. Ltd.

T2 Biosystems

0.1627
+0.01268.39%
Volume:71.86K
Turnover:11.80K
Market Cap:4.56M
PE:-0.04
High:0.1700
Open:0.1550
Low:0.1550
Close:0.1501
Loading ...
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2024

Major Issues Report

Form 8-K - Current report
Jul 27, 2024

Correspondence

Form CORRESP - Correspondence
Jul 19, 2024

Major Issues Report

Form 8-K - Current report
Jun 01, 2024

Correspondence

Form CORRESP - Correspondence
May 22, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 08, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 07, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]